Cervical HPV-16 and / or HPV-18 Infection
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
1
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
LP
Lee's PharmaceuticalChina - Guangzhou
1 program1
Yallaferon®， the recombinant human interferon α-2b gelPhase 2/31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Lee's PharmaceuticalYallaferon®， the recombinant human interferon α-2b gel
Clinical Trials (1)
Total enrollment: 100 patients across 1 trials
Recombinant Human Interferon a-2b Gel for HPV-16 and/ or HPV-18 Gynecological Infections
Start: Sep 2015Est. completion: Mar 2017100 patients
Phase 2/3Unknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space